Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)

NCT07253129 · clinicaltrials.gov ↗

RECRUITING

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T Cell Lymphoma

Interventions

PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
PROCEDURE: Allogenic stem cell transplant (ASCT)

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine